awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38842559-92839186-8B25-4A3C-891E-729766A1A676
Q38842559-92839186-8B25-4A3C-891E-729766A1A676
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38842559-92839186-8B25-4A3C-891E-729766A1A676
Lack of evidence for a harmful effect of sodium-glucose co-transporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized controlled trials.
P2860
Q38842559-92839186-8B25-4A3C-891E-729766A1A676
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38842559-92839186-8B25-4A3C-891E-729766A1A676
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
54c6ee329512954130f5c66823a04a9bd2669ad8
P2860
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus.